Loading...
33 Oncology Reports
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Bristol-Myers Squibb Company, GlaxoSmithKline, Johnson & Johnson, Roche, Merck
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico
Major Players: Abbvie, Merck, Pfizer, Beckton Dickinson, Bristol-Myers Squibb
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Abbott Laboratories, Amgen, Bristol-Myers Squibb, Novartis, Roche
Study Period: 2021 - 2030
Countries Covered: Brazil, Argentina, Mexico
Major Players: Abbott Laboratories, Amgen, Roche, GlaxoSmithKline, Novartis
Study Period: 2019 - 2030
Countries Covered: Brazil, Argentina
Major Players: Eisai, Bristol-Myers Squibb, Exelixis, Novartis, Bayer
Study Period: 2021 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Amgen, Bayer, Roche, Bristol-Myers Squibb, Abbott Laboratories
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Epigenomics, Abbott Laboratories, Roche, Novigenix, Amgen
Study Period: 2021 - 2030
Countries Covered: Saudi Arabia, United Arab Emirates, South Africa
Major Players: Bayer, Roche, Bristol-Myers Squibb, Abbott Laboratories, Amgen
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Novartis, Beckton Dickinson, Abbott Laboratories, Roche, GlaxoSmithKline
Study Period: 2019 - 2030
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: Abbott Laboratories, Roche, Boston Scientific, Bayer, Siemens Healthineers
Study Period: 2019 - 2030
Countries Covered: South Africa
Major Players: Abbott Laboratories, Merck, Takeda Pharmaceuticals, Siemens Healthineers, Roche
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Teleflex, Novartis, Elekta, Siemens Healthineers, Bayer
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Bayer, AstraZeneca, Sanofi, Thermo Fisher Scientific, Roche
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Study Period: 2019 - 2030
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: Eli Lilly and Company, Bristol-Myers Squibb, Roche, AstraZeneca, GlaxoSmithKline
Study Period: 2021 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Amgen, Bristol-Myers Squibb, Merck, Sun Pharmaceuticals Industries, Sanofi
Study Period: 2019 - 2030
Countries Covered: Germany, United Kingdom, France, Italy, Spain
Major Players: Roche, Siemens Healthineers, Johnson & Johnson, Eli Lilly and Company, GlaxoSmithKline
Study Period: 2021 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: AstraZeneca, GlaxoSmithKline, Johnson & Johnson, Roche, Siemens Healthineers
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Abbott Laboratories, Beckton Dickinson, Merck, Takeda Pharmaceuticals, GlaxoSmithKline
Study Period: 2019 - 2030
Countries Covered: Germany, United Kingdom, France, Italy, Spain
Major Players: Roche, Bristol-Myers Squibb Company, AstraZeneca, Johnson & Johnson, Endo International
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico
Major Players: Bristol-Myers Squibb Company, AstraZeneca, GlaxoSmithKline, Johnson & Johnson, Roche
Study Period: 2019 - 2030
Countries Covered: South Africa
Major Players: Pfizer, Johnson & Johnson, AstraZeneca, Bristol-Myers Squibb, Merck
Study Period: 2019 - 2030
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: Roche, Johnson & Johnson, Endo International, AstraZeneca, Bristol-Myers Squibb
Study Period: 2019 - 2030
Countries Covered: Brazil, Argentina
Major Players: AstraZeneca, Roche, GlaxoSmithKline, Johnson & Johnson, Siemens Healthineers
Study Period: 2019 - 2030
Countries Covered: South Africa
Major Players: AstraZeneca, Bristol-Myers Squibb, Roche, Johnson & Johnson, Siemens Healthineers
Study Period: 2019 - 2030
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: Pfizer, Roche, Bayer, Novartis, Eisai
Study Period: 2019 - 2030
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: Bristol-Myers Squibb, Novartis, Roche, Pfizer, Eli Lilly and Company
Study Period: 2019 - 2030
Countries Covered: Brazil, Argentina
Major Players: Bristol-Myers Squibb, Novartis, Roche, Pfizer, Eli Lilly and Company
Study Period: 2019 - 2030
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: Merck, Eisai, Abbott Laboratories, Roche, Takeda Pharmaceuticals
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Myriad Genetics, Pfizer, Novartis, AstraZeneca, Immunovia
Filter Reports
By Region
By Countries
